In addition, the expression of CD86 on cDCs was significantly up-regulated after TLRs stimulation in MS, while no difference existed in CD80 and CD86 expression of pDCs, indicating that cDCs were in a more activated state in MS (60). The gene discussed is CD86; the disease is myeloid sarcoma.